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Abstract
Genome-scale metabolic models bridge the gap between genome-derived bio-
chemical information and metabolic phenotypes in a principled manner, provid-
ing a solid interpretative framework for experimental data related to metabolic
states, and enabling simple in silico experiments with whole-cell metabolism.
Models have been reconstructed for almost 20 bacterial species, so far mainly
through expert curation efforts integrating information from the literature with
genome annotation. A wide variety of computational methods exploiting meta-
bolic models have been developed and applied to bacteria, yielding valuable
insights into bacterial metabolism and evolution, and providing a sound basis for
computer-assisted design in metabolic engineering. Recent advances in computa-
tional systems biology and high-throughput experimental technologies pave the
way for the systematic reconstruction of metabolic models from genomes of new
species, and a corresponding expansion of the scope of their applications. In this
review, we provide an introduction to the key ideas of metabolic modeling, survey
the methods, and resources that enable model reconstruction and reﬁnement, and
chart applications to the investigation of global properties of metabolic systems,
the interpretation of experimental results, and the re-engineering of their
biochemical capabilities.
Introduction
The ﬂow of genome sequencing, metagenome sequencing
and other high-throughput experimental efforts aimed at
exploring the space of microbial biochemical capabilities has
been steadily growing in recent years. At the time of writing,
more than 1800 bacterial genome-sequencing projects
have been initiated and nearly 650 have been completed
(http://www.genomesonline.org, http://www.ebi.ac.uk/integr8).
Combined with increasingly efﬁcient annotation methods,
these set the stage for the systematic identiﬁcation of most
enzymes encoded in the genomes of the corresponding
bacterial species. Avariety of so-called ‘-omics’ technologies
now routinely provide large-scale functional clues on mole-
cular interactions and cellular states, offering snapshots of
the dynamic operation of metabolism under speciﬁed con-
ditions, and adding to the store of accumulated knowledge
on microbial biochemistry and physiology.
Simultaneously, the expected wealth of new biochemical
activities, the progress of metabolic engineering techniques
aimed at harnessing these activities, and the perspective of
applications to white and green biotechnology have triggered
a strong renewed interest in the exploration of bacterial
metabolism. In addition to charting the range of naturally
evolved chemical transformations, relevant research ques-
tions include the following: How does the global metabolism
of a bacterium react to changes in its environment? What
kind of joint metabolic operation of distinct species can help
sustain a bacterial community? How can genomic and
biochemical information be best exploited to gain insights
into the relationship between an organism’s genotype and its
phenotype? For instance, can we predict changes in metabo-
lism-related phenotypic traits caused by simple or complex
genotype modiﬁcations? How did metabolic processes
evolve? How can metabolic networks be efﬁciently repro-
grammed for a variety of utilitarian purposes?
Investigationsof a bacterium’s metabolismare typically fed
by knowledge (ultimately from observations) at two different
scalesofdescriptionofthechemistry atworkwithincells.The
larger scale focuses on the physiology of the whole bacterial
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the relative quantities of chemical nutrients it requires for
growth? How efﬁcient is the cell at converting chemicals from
the environment into its own components? Such metabolic
capabilities resultfromthe coordinatedaction of the enzymes
expressed in the respective species, the knowledge of which
belongs to the ﬁner, molecular scale. Each of the correspond-
ing biochemical conversions can be identiﬁed either directly
by performing enzymatic assays, or indirectly, from the
genome sequence, through a homology relationship with
proteins whose function has been previously elucidated. To-
gether, the reactions that have been demonstrated to poten-
tially occur in the cell form the metabolic network of the
organism. Metabolic networks can thus be viewed as lists
of those molecular mechanisms (reactions) and associated
molecular components (enzymes, substrates, and products)
that are most directly related to the metabolic capabilities
mentioned above.
For a given bacterial species, confronting knowledge from
these two scales, molecular vs. cellular, can reveal inconsis-
tencies. For instance, it may happen that no sequence of
identiﬁed reactions is capable of producing one of the
essential cell components from the set of compounds avail-
able in a deﬁned growth medium, even though the species is
known to grow on that medium. Furthermore, when the two
scales are consistent, their relationship can be investigated
further in order to enumerate the possible implementations
of the physiology that the metabolic network can achieve.
Biochemists have traditionally performed such investigations
by modularizing the set of reactions into metabolic pathways,
typically grouping together reactions that allow the conver-
sion of one or more ‘input’ metabolites into ‘output’ meta-
bolites. Pathways boundaries are somewhat arbitrary, even
though inputs and outputs tend to be metabolites involved in
several reactions. Pathway-based analyses are thus focused on
the possible fates of a restricted number of compounds, and
are amenabletomanual expertise thanks to thesimpliﬁcation
brought by themodularizedview(Huangetal.,1999;Teusink
et al., 2005; Risso et al., 2008).
Yet, metabolic pathways typically involve a large number
of ‘side metabolites’ such as cofactors and byproducts of
chemical reactions, and metabolism is as much about
converting nutrient into cell components as it is about
regenerating cofactors and recycling (or secreting) ulti-
mately unused byproducts. The latter transformations typi-
cally involve several pathways, and are dependent on the
stoichiometry and rates of the reactions. Manual approaches
are insufﬁcient to assess their feasibility by a given network
for at least two reasons: metabolic networks are too large,
and the question requires a quantitative analysis.
Bridging that gap between knowledge of the metabolic
network structure and observed metabolic phenotypes is
precisely where metabolic models come into play. Generally
speaking, a model of a natural system is one of many
possible mathematical representation of that system,
explicitly describing some of its features and supporting
predictions on some other features, the latter being typically
time- or environment dependent. In this particular case,
knowledge of the metabolic network alone is not quite
sufﬁcient to predict the metabolic capabilities of a cell. Also
needed are a structured (mathematical) representation of
that network, together with a set of rules and possibly
quantitative parameters enabling simulations or predictions
on the joint operation of all network reactions in a given
environment, and in particular predictions on the values of
metabolite ﬂuxes and/or concentrations (Papin et al., 2003).
The above, in short, constitutes a metabolic model.
Constraint-based genome-scale models of metabolism
(Palsson, 2006) are a category of models precisely aimed at
assessing the physiological states achievable by a given meta-
bolic network, and at uncovering their biochemical imple-
mentation in terms of metabolic ﬂuxes. They offer an
idealized view of the cell as a set of ‘pipes,’ with metabolites
ﬂowing through each pipe, and biochemical conversions
taking place at junctions between pipes. Some metabolites
canalsobeexchangedwiththeenvironment,ﬂowinginorout
of the system through dedicated pipes that can be opened or
shut, and may have upper bounds on their throughput. The
cell is required to achieve balanced production and consump-
tion of all the intermediate substrates and products involved
in its metabolism: what ﬂows in a junction must ﬂow out.
Constraint-based models can help investigate in a sys-
tematic manner most of the research questions listed at the
start of this introduction, because they provide a way to
explore the consequences on the operation of the entire
metabolic network of the piecemeal information available
on each of its parts. They are especially well suited to ‘what
if’ experiments involving genetic or environmental pertur-
bations, such as: how would the cell behave in an environ-
ment with a different chemistry than the ones that have been
experimented on? How would one or more deletions affect
its metabolic capabilities? Which deletions would maximize
the production of both metabolite x and biomass?
Before a model for a given species can be used to gain new
insights into its metabolic capabilities or evolutionary
history, it must ﬁrst be built from the scattered genomic,
biochemical, and physiological information available on
that species up to a point where known physiology can be
predicted from biochemistry without major mistakes. This
process is sometimes known as ‘model reconstruction’; its
endpoint is a functional genome-scale model, i.e. a struc-
tured representation of the current state of knowledge
on the metabolism of the respective species (Reed et al.,
2006a). The model provides a framework to interpret new
experimental data gathered at the cellularor molecular scale.
That data may be incompatible with the current model, in
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possible revisions or improvements. If, on the other hand,
data and model are compatible, the new evidence may still
narrow down the set of possible metabolic behaviors of the
cell, thus enriching the model (Covert et al., 2004).
This review article covers both the reconstruction of
genome-scale metabolic models and their applications
to basic and applied research in microbiology. Following a
primer on constraint-based models, we will review the state
of the art in model reconstruction. Next, we will survey the
main applications of metabolic models, from phenotype
predictions to data interpretation or metabolic engineering.
Practical aspects of direct relevance to the working micro-
biologist will be covered by a sketch of the main dedicated
database and software resources. We will conclude the
review with a discussion on future directions in the ﬁeld.
Foundations of genome-scale metabolic
modeling
The metabolic state of a cell and its variation over time can
be described by metabolite concentrations and reaction
rates, which can be viewed as the ‘endpoints’ of metabolic
operation. These quantities are related by the law of con-
servation of matter, which states that the net production rate
of a metabolite equals the sum of the rates of the reactions
consuming or producing it, weighted by the associated
relative stoichiometric coefﬁcients. Conversely, enzyme
kinetics express reaction rates as complex functions of
metabolite concentrations and enzymatic activities, which
vary over time as a result of transcriptional and metabolic
regulation (Smallbone et al., 2007). Deriving meaningful
predictions from these two types of equations for large
metabolic systems is a very challenging proposition, not
only because of the mathematics, but also because many of
the parameters are not known, difﬁcult to measure, and
possibly context dependent. In practice, these pitfalls restrict
the use of kinetic modeling to metabolic systems much
smaller than ‘whole-cell’ metabolic networks, which typi-
cally include hundreds of reactions for a bacterium.
Constraint-based models bypass these difﬁculties by
focusing on the average reaction rates achievable by cells
grown in steady or slowly varying environmental condi-
tions. Rates are typically averaged over minutes, ﬁtting with
the typical time scale of uptake or secretion rates measure-
ments. Such averages are not affected by transient states
because the characteristic relaxation time of metabolic
systems – i.e. the time it takes for chemical reactions within
the cell to reach a steady state – is much shorter than a
minute. Moreover, because environmental changes and
variations of enzyme concentrations occur on longer time
scales, one need not take into account regulatory changes to
assess average reaction rates over minutes. Turnover rates of
most intracellular metabolites are high in bacterial cells
(Stephanopoulos et al., 1998). At the time scale considered
here, their concentrations have therefore generally reached
steady levels, and remain constant as long as environmental
conditions do not change. As a consequence, the law of
conservation of matter constrains the production and con-
sumption rates of these metabolites to be balanced. These
assumptions are usually summarized under the expression
steady-state hypothesis and the corresponding constraint on
reaction rates as a mass balance (or stoichiometric) con-
straint (Stephanopoulos et al., 1998). Obviously, this rea-
soning applies only to metabolites that are neither taken in
from an external pool (e.g. nutrients) nor excreted from the
cell or accumulated in large quantities (e.g. cell components
such as nucleic acids, amino acids, or some lipids). For each
metabolite that can be ‘balanced,’ the mass balance con-
straint can be expressed mathematically by a linear equation
relating reaction rates of the form
P
sjnj=0, where sj is the
stoichiometric coefﬁcient of the metabolite in reaction j, and
nj the rate of reaction j.
In addition to mass balance constraints, reactions that are
known to be thermodynamically irreversible in vivo are
constrained to have a non-negative reaction rate. Similarly,
upper bounds on the reaction rates can be known from
measurements or theory and included in the model as
additional constraints on the reaction ﬂuxes (Reed &
Palsson, 2003).
Mass balance, irreversibility and upper-bound constraints
result from the application of simple laws of physics to
individual reactions or metabolites from the network. These
constraints propagate from reaction to reaction throughout
the metabolic network; the constraint-based modeling
framework is designed to automatically compute the result-
ing balance. To that end, it makes use of a succinct
mathematical representation of all reaction stoichiometries:
the stoichiometric matrix (see Fig. 1). In this matrix, columns
represent reactions and rows metabolites. The stoichio-
metric coefﬁcient of a metabolite within a reaction is
included at the intersection of the corresponding row and
column (see Fig. 1). Reaction rates are represented in
constraint-based models by single numbers, the reaction
ﬂuxes, which are normalized by the weight of the cells
harboring the reactions to account for the size of the colony
(a reaction ﬂux is typically expressed with the Unit
mmolh
 1g
 1dry wt). Because the goal is to describe the
joint operation of many metabolic reactions, it is convenient
to deﬁne a ﬂux distribution as a collection of reaction ﬂuxes
covering the entire system. Under the steady-state approx-
imation, the concentrations of balanced metabolites being
constant, a ﬂux distribution carries sufﬁcient information to
completely describe a state of the system. Using the stoichio-
metric matrix, a simple matrix equation – summarizing all
mass balance equations shown above – can then be used to
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S.n=0, where S is the stoichiometric matrix and n the ﬂux
distribution represented as a vector.
A precise deﬁnition of the boundary of the system to be
modeled is also needed to formulate an explicit mathematical
representation. The system typically includes the whole cell
and its vicinity, in order to encompass all the exchanges of
matter between the cell and its environment. Transport
reactions that allow for exchange of speciﬁc metabolites with
the extracellular space through the membrane are also in-
cluded in the model. Environmental conditions are then
modeled by acting on the balance of the external metabolites:
metabolites that are available from the environment can be
taken up by transporters while the others can only be excreted.
A ﬂux distribution that is compatible with all the con-
straints in a given environment is considered achievable (or
feasible) by the cell, whereas a distribution that violates at
least one of these constraints is not. The simplicity of the
system of linear equations that represent constraints is one
of the main strengths of the framework, because it permits
fast assessments of the feasibility of a ﬂux distribution using
a computer and standard algorithms.
The simplicity of constraint-based models comes at the
expense of a number of limitations in their predictive
capabilities. Such models focus solely on reaction ﬂuxes,
and completely ignore the inﬂuence of metabolites and
enzymes. In reality, however, enzyme kinetics, and tran-
scriptional or metabolic regulation may signiﬁcantly inﬂu-
ence reaction ﬂuxes. Regulation can for instance limit the
use of a pathway by downregulating some of its enzymes
when particular environmental conditions are met. These
mechanisms, if they could somehow be taken into account,
Fig. 1. Genome-scale modeling of metabolism. A metabolic network (top left) is transformed into a model by deﬁning the boundaries of the system, a
biomass assembly reaction, and exchange ﬂuxes with the environment (top right). Using the corresponding stoichiometric matrix (bottom right), the
achievable ﬂux distributions compatible with enforced constraints can be found (a particular one is depicted in the bottom left ﬁgure).
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straint-based models. In other words, models may allow ‘false-
positive’ metabolic states, which respect the enforced meta-
bolic constraints but are inconsistent with other biological
processes. Several attempts have been made to extend the
constraint-based modeling framework, in order to account for
regulatory interactions (Covert et al., 2001), signaling pro-
cesses (Lee et al., 2008b), the ﬁrst and second laws of
thermodynamics (Beard et al., 2002, 2004), or metabolite
concentrations (K¨ ummel et al., 2006b; Henry et al., 2007).
Nevertheless, these extensions require the inclusion of addi-
tional experimental data and may result in more complex
mathematical formulation hindering their practical use.
Some predictions of constraint-based models may be
wrong in cases where modeling assumptions do not hold.
For instance, some metabolites do accumulate in the cell, and
the mass balance assumption clearly does not hold for these.
In general, the concentration of speciﬁc metabolites may be
high enough relatively to the ﬂuxes they are involved in for the
m a s sb a l a n c ea p p r o x i m a t i o nt ob e c o m ec l e a r l yf a l s e .
In practice, many of the analytical methods that have
been developed for constraint-based models focus on deﬁn-
ing and characterizing sets of feasible ﬂux distributions.
Others focus on a single distribution. The diversity of ﬂux
distributions compatible with constraints in a given envir-
onment can be viewed as reﬂecting the diversity of the
metabolic states the cell may ﬁnd itself in. Nevertheless, the
space of feasible ﬂux distributions features biologically
informative properties whose determination requires ade-
quate techniques; these will be introduced in the next
sections of this review.
Building the models
The level of detail necessary to build a constraint-based model
of a bacterium’s metabolism is relatively low; the only
information required is the precise reaction stoichiometries
and directions, in order to account for mass balance and
irreversibility constraints. To reﬂect the global biochemical
capabilities of the organism, the model also needs to encom-
pass the complete set of metabolic activities that can occur
within it – or a reasonable approximation thereof. This
comprehensiveness requirement and the high number of
metabolic reactions make the actual construction of such
models a challenging task in itself. In this section, we will
review the main methods and resources helping in this task.
We will ﬁrst show how information from genome annotation
can be used to infer biochemical reactions at large scale, a task
commonly called metabolic network reconstruction.W ew i l l
then review the techniques commonly used to assess the
consistency of reconstructed models, and show how missing
biochemical activities can be identiﬁed to complete the model.
Initial reconstruction of metabolic models
T h em o s tr e l i a b l ee v i d e n c ef r o mw h i c ht h ep r e s e n c eo fa
metabolic reaction in a species can be inferred is experimental
proof of the respective biochemical activity. Such biochemical
results have been accumulated for several decades, mostly from
dedicated experiments targeting well-deﬁned activities. As a
consequence, the corresponding reactions have often been
precisely and reliably characterized. Exploiting these results to
reconstruct the whole metabolism of an organism is a labor-
intensive task, however, as it requires processing a high volume
of literature. Most existing metabolic models have been recon-
structed in this manner and for extensively studied organisms.
For instance, the most complete bacterial model available to
date – namely iAF1260, the latest model of Escherichia coli
metabolism – includes references to more than 320 articles
(Feist et al., 2007). Two types of databases centralize biochem-
ical knowledge: enzyme-centric ones, which collect functional
information acquired on enzymes, for example BRENDA
(Barthelmes et al., 2007) or SwissProt (Boutet et al., 2007);
and pathway databases, aimed at describing the biochemistry
of metabolic processes, for example EcoCyc for E. coli
metabolism (Karp et al., 2007) or UM-BDD for microbial
biodegradation pathways (Ellis et al., 2006) (see Table 1).
These biochemical clues are typically incomplete rela-
tively to the set of all possible activities, especially for less
studied organisms. In addition, while technologies aiming at
high-throughput characterization of biochemical activities
are improving, they are not yet mature enough to provide
reasonably good coverage. Genes corresponding to enzymes
that have been experimentally characterized have never-
theless been identiﬁed. Their homologues in the genome of
such species can be identiﬁed using comparative genomics
methods, thereby indicating the presence of the associated
biochemical activities.
The traditional path to inferring metabolic reactions from
the genome of an organism is gene-centric, at least in its ﬁrst
steps. Nearly all available genome sequences are now system-
atically processed through automated annotation pipelines,
which identify coding sequences and infer functional annota-
tions. Covering all relevant methods would be beyond the
scope of this article, but thorough reviews can be found else-
where (M´ edigue & Moszer, 2007). Basically, coding sequences
are ﬁrst identiﬁed using highly efﬁcient gene-ﬁnding algo-
rithms [such as GENEMARK (Besemer et al., 2001), GLIMMER
(Delcher et al., 1999), or AMIGENE (Bocs et al., 2003)], which
discard the ORFs that are not likely to be coding for a protein.
Functional annotations are then sought for each gene using
complementary approaches: sequence homology with pro-
teins of known function [stored for instance in UniprotKB
(UniProt, 2008)], conservation of genomic structure with
annotated species (e.g. synteny), and prediction of functional
domains (Apweiler et al., 2000; Claudel-Renard et al., 2003).
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increases the reliability of the annotation transfers from
proteins of known function to new genes. Current annotation
pipelines succeed at assigning a function to 50–80% of the
genes (Serres et al., 2004). A numberof databases provide such
automatically generated annotations for most sequenced
bacterial genomes (see Table 1).
In order to build a metabolic model, it is necessary to
identify the speciﬁc chemical conversions catalyzed by each
enzyme, together with the corresponding stoichiometries.
Functional annotations of enzymes therefore need to be
translated into appropriate chemical equations. The Enzyme
Commission (EC) numbers classiﬁcation offers an unam-
biguous way to identify enzyme-catalyzed reactions. When
provided by the enzyme annotations, these numbers directly
specify which reactions they catalyze. Several enzyme and
metabolic databases provide the correspondence between
EC numbers and reactions (see Tables 1 and 2). These
Table 1. Data sources for metabolic model reconstruction and reﬁnement
DNA sequence and genome annotation databases
DDBJ http://www.ddbj.nig.ac.jp/ General nucleotide sequence database
EMBL http://www.ebi.ac.uk/embl/ General nucleotide sequence database
GenBank http://www.ncbi.nlm.nih.gov/Genbank/ General nucleotide sequence database
Integr8 http://www.ebi.ac.uk/integr8/ Integrated information on complete genomes
CMR http://cmr.jcvi.org/ Integrated information on complete prokaryotic genomes
IMG http://img.jgi.doe.gov/ Integrated system for analysis and annotation of microbial genomes
SEED http://seed-viewer.theseed.org/ Integrated system for analysis and annotation of genomes using functional
subsystems
Protein and enzyme databases
BRENDA http://www.brenda-enzymes.info/ Comprehensive enzyme information system gathering data collected from the
literature by curators
ENZYME http://www.expasy.ch/enzyme/ Enzyme nomenclature database providing extensive information on all enzymes
with an associated EC number
UniProt http://www.ebi.ac.uk/uniprot/ Universal Protein Resource gathering protein sequences and annotations from
SwissProt (manually reviewed), trEMBL (computer annotated), and PIR
TransportDB http://www.membranetransport.org/ Predictions of membrane transport proteins for fully sequenced genomes
PSORTdb http://db.psort.org/ Repository of experimentally determined and predicted protein localizations
Prolinks http://prolinks.mbi.ucla.edu/ Database of predicted functional links between proteins
STRING http://string.embl.de/ Database of known and predicted protein–protein interactions
Metabolic databases
CheBI http://www.ebi.ac.uk/chebi/ Database on small molecules of biological interest
Pubchem http://pubchem.ncbi.nlm.nih.gov/ Database on small molecules
LipidMaps http://www.lipidmaps.org/ Database on lipid metabolites
Reactome http://www.reactome.org/ Curated database of biological pathways
KEGG http://www.genome.jp/kegg/ Suite of databases comprising information on compounds, reactions, pathways,
genes/proteins
BioCyc http://www.biocyc.org/ Collection of organism-speciﬁc pathway/genome databases, including a curated
multiorganism pathway database: MetaCyc
UniPathway http://www.grenoble.prabi.fr/
obiwarehouse/unipathway/
Curated resource of metabolic pathways linked to UniProt enzyme database
UM-BBD http://umbbd.msi.umn.edu/ Database on microbial biocatalytic reactions and biodegradation pathways
Experimental data repositories
IntAct http://www.ebi.ac.uk/intact/ Repository of reported protein interactions
DIP http://dip.doe-mbi.ucla.edu/ Database of experimentally determined interactions between proteins
Array Express http://www.ebi.ac.uk/aerep/ Public repository of microarray data
GEO http://www.ncbi.nlm.nih.gov/geo/ Public repository of microarray data
ASAP http://asap.ahabs.wisc.edu/ Repository of results of functional genomics experiments for selected bacterial
species
E. coli multi-omics DB http://ecoli.iab.keio.ac.jp/ Comprehensive dataset of transcriptomic, proteomic, metabolomic, and ﬂuxomic
experiments for E. coli K12
Systomonas http://www.systomonas.de/ Repository of ‘omics’ datasets and molecular networks for pseudomonads species
PubMed http://www.pubmed.org/ Database on biomedical literature
Metabolic model repositories
BiGG http://bigg.ucsd.edu/ Repository of reconstructed genome-scale metabolic models
BioModels http://www.ebi.ac.uk/biomodels/ Database of mathematical models of biological systems
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known biochemical reactions with the associated chemical
information, including stoichiometry: they include most of
the reference knowledge needed to build metabolic models.
Several issues hinder this translation process. First, enzy-
matic activities that have been identiﬁed only recently are
usually not included in the EC classiﬁcation. Furthermore, full
EC numbers are not always systematically assigned in the
annotation process. As a result, many annotations retrieved
from protein databases are only textual (as in UniProtKB) or
ontologybased[asinGeneOntology(Ashburneret al.,2000)]
and do not provide the required metabolic information
directly. To address this shortcoming, PATHOLOGIC,t h em e t a -
bolic network reconstruction software tied to the BioCyc
metabolic databases, includes an algorithm performing the
identiﬁcation of gene-reaction links from textual annotations
(Karp et al., 2002) (see Table 3). This procedure relies on a
dictionary of synonyms, however, and may fail at recognizing
an explicit reaction when uncommon terms are used. An
expert curation step is thus necessary, for which metabolic
pathway databases provide useful guidance. Recent initiatives
speciﬁcally aim at solving this issue: for instance, textual
annotations in UniProtKB/SwissProt are being progressively
replaced by direct references to reactions from UniPathway, a
metabolic database in which all reaction steps are speciﬁed up
to the chemical level (see Table 1).
The broad speciﬁcity of some enzymes may also signiﬁ-
cantly increase the number of distinct reactions they can
catalyze. For instance, enzymes annotated with alcohol
dehydrogenase activity (EC 1.1.1.1) may catalyze the degra-
dation of several distinct alcohols. Similarly, enzymes acting
on lipids are often not speciﬁc to the length of their carbon
chain. In such cases, functional annotations often report the
activity using generic metabolites (e.g. ‘an alcohol’ or ‘a fatty
acid’) representing the entire set of possible substrates.
Instantiating reactions with speciﬁc metabolites is required
when building a metabolic model, however, as accounting
for the mass balance constraint requires that all metabolites
should be well deﬁned. It is thus necessary to identify for
each generic compound the corresponding set of speciﬁc
compounds, as much for primary substrates as forcofactors.
This task is complicated by the combinatorial effect, because
the number of substrate combinations may signiﬁcantly
increase the number of speciﬁc reactions. To address this
issue, databases of chemical species can be used to identify
all metabolites of a given chemical category (see Tables 1 and
2). In order to determine which metabolites are preferen-
tially recognized by enzymes, processing the literature or
browsing information collected in enzyme databases such as
BRENDA (Barthelmes et al., 2007) is often necessary.
Metabolites involved in metabolic pathways that have
already been inferred may also help in selecting the most
relevant substrates.
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170 M. Durot et al.Alternative approaches to metabolic network reconstruc-
tion bypass the classical annotation step altogether, taking
instead advantage of the curated links between enzyme-
encoding gene sequences and reactions [or EC numbers, as
in the Genome-Based Modeling (GEM) system (Arakawa
et al., 2006)] provided by some metabolic databases. Orthol-
ogy relationships are sought between reference sequences
fromthese databases and the coding sequences from the new
genome. While these methods [e.g. AUTOGRAPH (Notebaart
et al., 2006), or IDENTICS (Sun & Zeng, 2004), see Table 3]
simplify the reconstruction process, they usually do not
beneﬁt from advanced annotation techniques, such as those
derived from structural genomics or domains recognition,
and are more difﬁcult to combine with expert annotation.
They are also conditioned on the availability of curated
gene-reaction associations for a set of reference organisms.
The reconstruction of the metabolism of a new organism
can also beneﬁt from the knowledge of complete pathways
in related organisms. Metabolic databases often group
reactions into pathways or modules that indicate known
co-occurrence relationships between reactions that hold
across several organisms. Three main resources provide this
type of information: MetaCyc (Caspi et al., 2006), KEGG
Modules (Kanehisa et al., 2007), and SEED (Overbeek et al.,
2005) (see Tables 1 and 2). Metabolic model reconstruction
procedures tied to such databases can exploit the known co-
occurrences of reactions across reference organisms whose
metabolism has been extensively studied (Arakawa et al.,
2006). An instance of a reconstruction procedure taking
advantage of this notion of metabolic context is again
PATHOLOGIC, which infers the presence of pathways rather
than that of single reactions when possible. A reconstruction
procedure based on the SEED database was also proposed
recently (DeJongh et al., 2007); it includes a check that the
inferred pathways can be properly connected to form a
‘working’ model. By leveraging a speciﬁc form of ‘guilt-by-
association,’ approaches of this type may be able to retrieve
reactions catalyzed by enzymes that cannot be correctly
identiﬁed using current methods. In addition, the presence
of spontaneous reactions in the organism may be identiﬁed
by the occurrence of neighboring reactions in reference
metabolic pathways.
In addition to their equations, the reversibility and
localization of reactions need to be determined for meta-
bolic models. Few metabolic or enzyme databases report on
the reversibility of reactions in in vivo conditions (see Table
2). When not found in the literature, reversibility is there-
fore often determined using simple thermodynamic con-
siderations based on the reaction Gibbs energy, if it is
known, or on basic rules depending on the energy equiva-
lents (e.g. NADH or ATP) involved in the reactions (Ma &
Zeng, 2003; K¨ ummel et al., 2006a). Even though very few
compartments divide bacterial cells (with periplasm and
cytoplasm as the only main compartments in gram-negative
bacteria), the presence of such physical separation between
metabolites need to be included in their metabolic models.
Enzymes present in one compartment cannot interact with
metabolites present in another one. To properly model the
effect of compartments, the localization of enzymes and the
transport of metabolites need to be determined. Informa-
tion on the localization of enzymes and reactions is seldom
included in metabolic databases. Curated versions of BioCyc
databases, especially MetaCyc, are a welcome exception,
however (Caspi et al., 2006). When not found in the
literature, localization can be inferred using ab initio predic-
tions from enzyme sequences (Schneider & Fechner, 2004),
Table 3. Methods for model reconstruction
Metabolic model reconstruction (beyond the use of dedicated metabolic databases)
Identiﬁcation of metabolic reactions from textual gene annotations Karp et al. (2002)
Direct inference of metabolic reactions from genome sequence Sun & Zeng (2004), Arakawa et al. (2006), Notebaart et al. (2006)
Use of metabolic context to complete pathways Karp et al. (2002), Arakawa et al. (2006), DeJongh et al. (2007)
Metabolic model consistency checks
Flux variability analysis: identiﬁcation of reactions that are predicted to never
carry any ﬂux
Mahadevan & Schilling (2003)
Identiﬁcation of dead-end metabolites, which can never be produced or
consumed.
Segre ` et al. (2003), Ebenh¨ oh et al. (2004), Imielinski et al. (2005),
Kumar et al. (2007)
Assessment of thermodynamic consistency and assignment of reaction
directions.
Yang et al. (2005), K¨ ummel et al. (2006a,b)
Gap ﬁlling and model expansion
Graph-based metabolic network expansion using shortest metabolic paths Arita (2003), Boyer & Viari (2003)
GapFill: optimization-based network expansion and reaction reversibility
changes to solve dead-end metabolite inconsistencies
Kumar et al. (2007)
Optimization-based metabolic network expansion to resolve inconsistent
growth phenotypes
Reed et al. (2006a,b)
Network-based identiﬁcation of candidate genes for orphan metabolic activities Osterman & Overbeek (2003), Green& Karp (2004), Chen & Vitkup
(2006), Kharchenko et al. (2006), Fuhrer et al. (2007)
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171 Genome-scale models of bacterial metabolismor determined experimentally, for example using ﬂuores-
cence microscopy (Meyer & Dworkin, 2007). Transport of
metabolites can be inferred using comparative genomics
tools that identify transport enzymes [e.g. TransportDB
(Ren et al., 2004)]. Yet, such methods hardly determine the
speciﬁcity of transporters; knowledge of transported meta-
bolites is therefore often completed using direct information
on the microorganism’s physiology and the metabolites it
was shown to utilize in growth experiments.
Overall, reconstructing a constraint-based model for an
organism’s metabolism involves collecting various types of
information. A summary of the respective contributions of
each datasource to the model construction isshown in Table 2.
Checking the consistency of reconstructed
models
Once a draft metabolic model is obtained, its consistency
can be checked using a set of simple tests (see Fig. 2): is the
model chemically and physically coherent? Are there re-
maining ‘dead-ends’ in metabolic pathways or reactions
bound to be inactive? Is the model able to produce essential
metabolites from a known growth medium?
Constraint-based metabolic models fundamentally rely
on reaction stoichiometries to properly account for the mass
balance in metabolism at steady state. It is therefore crucial
that all chemical equations are correctly balanced to avoid
unrealistic creation or destruction of matter. To control the
correctness of the reaction stoichiometries, the atom balance
of each reaction can be checked using the chemical formulae
of the metabolites, which are typically found in databases of
chemical compounds (see Table 1). For cases where the
formula is not available for all metabolites, a method was
recently introduced to detect such balance errors in meta-
bolic models by solely comparing chemical equations – for
instance, reactions A ! B and A ! B1C would be identi-
ﬁed by this method as ‘stoichiometrically inconsistent,’
because balancing both equations would require that at
least one of the metabolites has a null or negative mass
(Gevorgyan et al., 2008).
The assumptions on which constraint-based models are
founded do not enforce thermodynamic consistency on the
ﬂuxes. Flux distributions obeying conservation of mass can
still include internal cycles that violate thermodynamic laws,
allowing for instance the artiﬁcial generation of high-energy
cofactors. To prevent models from predicting such unrealis-
tic metabolic modes, extensions of the modeling framework
were proposed that directly enforce these laws (Beard et al.,
2002). Their nonlinear nature entails costly computations,
however, which hinder the use of such modeling extensions
in practice. In order to provide thermodynamically consis-
tent models without including such extensions, methods
have been developed to detect inconsistent cyclic modes in
draft metabolic models, and propose changes in reaction
reversibility that would avoid those modes from being
predicted (Yang et al., 2005; K¨ ummel et al., 2006a).
Before one can reap the beneﬁts of having a model, the
model should be functional, i.e. it should be checked that
non-null ﬂuxes can actually be predicted. This relates to the
completeness of the model, because for instance a missing
Fig. 2. Pipeline for model reconstruction and
reﬁnement. An initial model is reconstructed
from genome annotations and from preexisting
knowledge on the species’ biochemistry and
physiology. Besides collecting the biochemical
activities, this task includes several additional key
steps. The resulting model is then iteratively
corrected and reﬁned, according to internal
consistency criteria and by comparing its
predictions to experimental data.
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172 M. Durot et al.reaction in alinear pathwaywould prevent any non-null ﬂux
from being predicted in it at steady state, thereby inactivat-
ing all other reactions in the pathway. Metabolites that are
never consumed or never produced, so-called ‘dead-ends,’
typically reveal that reactions are missing. In order to help
investigate and correct these so-called ‘metabolic gaps,’
methods have been developed that assess whether reactions
can be active in the model (Reed & Palsson, 2004), identify
dead-end metabolites (Kumar et al., 2007) or directly track
the producibility of metabolites from source metabolites
(Segre ` et al., 2003; Ebenh¨ oh et al., 2004). In case the model is
later used to predict growth phenotypes (see Applications of
metabolic models), the producibility of biomass precursors
and the completeness oftheir biosynthetic pathways should be
especially checked beforehand. Dedicated procedures have
been designed to systematically perform these checks for
newly reconstructed models (Segre ` et al., 2003; Imielinski
et al., 2005; Senger & Papoutsakis, 2008). Solving such
inconsistencies often involves ﬁlling metabolic gaps or com-
pleting the network with additional metabolic pathways.
The methods presented in this section check the consistency
of the reconstructed model with respect to a set of basic rules
(see Table 3). We will review in the section on model applica-
tions how model predictions can also be confronted with
experimental data, providing consistency checks of the model
with respect to diverse additional experimental evidence.
Interpreting and solving identiﬁed inconsistencies of either
type are key to improving the quality of the metabolic model.
Targeted searches for missing metabolic
activities
Consistency checks (either internal to the model or relative to
experimentaldatasets) mayshow that thereconstructedmodel
is incomplete and lacks some metabolic reactions. Resolving
these metabolic gaps entails expanding the model by identify-
ing and including missing biochemical activities. This process
basically consists of two steps: (1) identifying plausible candi-
date reactions that could complete the model and (2) ﬁnding
genes that could catalyze the hypothesized activities.
Reactions contained in metabolic databases are the pri-
mary source of information for completing the metabolic
model (see Table 1). The search for candidate reactions
within these databases can be facilitated using knowledge of
existing pathways (as in MetaCyc, SEED, or UM-BBD, see
Table 1) or computational methods (Arita, 2003; Boyer &
Viari, 2003; Kumar et al., 2007) (see Table 3). In the latter
category, the GapFill method was speciﬁcally developed to
identify dead-ends in models, and correct them by adding
reaction from a global repository of reactions, changing the
reversibility status of reactions, or adding transporters
(Kumar et al., 2007). The addition of reactions to the model
is guided by an optimization step minimizing the number of
reactions. Similarly, Reed et al. (2006b) proposed a method
which drives the expansion of the metabolic model to
account for the utilization of additional external com-
pounds. For metabolites experimentally shown to be used
by the organism but not predicted as such by the model (see
Applications of metabolic models on growth phenotype
predictions for methods to perform these predictions), their
method automatically proposes minimal sets of reactions
froma repositoryof reactionsthat, if added, would allow the
model to exploit the external metabolites.
The set of reactions referenced in metabolic databases is far
from being comprehensive: the right candidates for complet-
ing the model may not yet be known. Computational and
experimental approaches have been proposed to extend this
‘universe of possible reactions.’ On the computational side,
several methods originating from the ﬁeld of chemo-infor-
matics have been designed to infer chemical transformations
(Gasteiger, 2005). Some of them have been more speciﬁcally
adapted to biochemical transformations, using rules on enzy-
matic conversions to infer new conversions for biologically
relevant metabolites (Klopman et al., 1994; Arita, 2000;
Hatzimanikatis et al., 2005; Ellis et al., 2008).
Numerous experimental methods are also being devel-
oped to explore the range of possible biochemical reactions.
MS and nuclear magnetic resonance (NMR) techniques are
able to identify and quantify large sets of metabolites at high
throughput (Dunn et al., 2005; Dettmer et al., 2007).
Computational methods have been proposed to infer reac-
tions from MS data, by analyzing mass differences between
related metabolites (Breitling et al., 2006) or correlations
between metabolite concentrations across distinct conditions
(Steuer, 2006). They do not provide direct evidence for bio-
chemical transformations, however: their predictions should be
treated as clues to be conﬁrmed by additional information.
Although mostly used to determine metabolic ﬂuxes, atom-
labeling experiments could also become powerful tools to
elucidate novel metabolic pathways (Sauer, 2006). They can
advantageously complement computational ab initio pathway
inference methods by selecting candidate pathways that are
compatible with observed isotopic patterns. Finally, untargeted
enzyme activity screenings have recently been performed to
identify the substrates of enzymes of unknown function and
discover novel activities (Saghatelian et al., 2004; Saito et al.,
2006). The availability of large-scale libraries of ORF clones
(Kitagawa et al., 2005) should increase the likelihood of such
methods expanding the store of known reactions.
The search for candidate genes for orphan metabolic
activities is in some ways the reverse of the classical genome
annotation problem (i.e. searching the function of identiﬁed
genes). Yet, many of the tools developed to determine gene
functions can be adapted for this purpose. Sequence homol-
ogy to already characterized genes is central to most
methods for candidate gene detection, but combining it
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performance. For instance, several approaches exploit func-
tional links, such as gene neighborhood, gene co-expression,
protein interaction, or phylogenetic co-occurrence, to relate
candidate genes with genes involved in the same metabolic
pathways or close in the metabolic network (Osterman &
Overbeek, 2003; Green & Karp, 2004; Chen & Vitkup, 2006;
Kharchenko et al., 2006; Fuhrer et al., 2007). Databases such
as STRING (von Mering et al., 2007) or Prolinks (Bowers
et al., 2004) compile large sets of functional links across a
wide range of organisms. On the experimental side, enzyme
activity screenings are used to validate the generated candi-
dates. Furthermore, when the orphan activity is associated
to a speciﬁc phenotype, screens of systematic knockout
mutant phenotypes can help in identifying candidates
(Aghaie et al., 2008).
The two types of methods – ﬁnding candidate reactions
or candidate genes – beneﬁt from being used in combina-
tion, as identifying genes for putative reactions can help in
selecting the proper reactions to include.
Applications of metabolic models
A wealth of computational methods has been developed to
help analyze biological properties revealed by reconstructed
metabolic models. Not only would a comprehensive and
technical description exceed the scope of this review, but
these methods have been extensively covered elsewhere,
either on the technical side (Price et al., 2004) or for
applications on a speciﬁc organism, i.e. E. coli (Feist &
Palsson, 2008). We will provide here the reader with a review
on the main applications for which constraint-based models
have been most successful and are mostly promising for
bacterial species. We will distinguish four main types of
applications: (1) analysis of network properties of metabo-
lism, (2) prediction and analysis of bacterial growth pheno-
types, (3) model-based interpretation of experimental data,
and (4) metabolic engineering.
Analysis of network properties
The principle of constraint-based modeling consists in study-
ing the set of reaction ﬂuxes – namely ﬂux distributions – that
are achievable at steady state given the constraints imposed on
the system. Reaction ﬂuxes can vary inside a continuous set of
possible values. This set can encompass signiﬁcant variability
at the level of individual pathway or reaction ﬂuxes. A wide
range of methods have been designed to explore that varia-
bility and analyze speciﬁc properties of metabolites and
reactions which emerge from the ﬂux constraints.
One approach consists in sampling the set of achievable
ﬂux distributions (Almaas et al., 2004; Reed & Palsson, 2004;
Wiback et al., 2004). Methods that provide a uniform
sampling of the possible states have been proposed (Almaas
et al., 2004; Wiback et al., 2004). By sampling a signiﬁcant
number of metabolic states, these approaches offer an over-
view of the range of ﬂux distributions that can occur in the
metabolic network at steady state. The ‘uniform’ nature of
the sampling is based only on the mathematical description
of the set of possible ﬂux distributions, avoiding any prior
assumption on which metabolic states are most likely to be
selected in vivo. For instance, these sampling methods have
been used to evaluate the relative occurrence of reactions
within the set of possible ﬂux distributions and across
several environmental conditions (Almaas et al., 2004). This
analysis showed that a few reactions are active in many
sampled ﬂux distributions and carry high ﬂuxes – forming a
so-called high-ﬂux metabolic backbone – while many others
are active in few sampled ﬂux distributions and carry low
ﬂuxes. Similar methods were also used to evaluate the
correlation of ﬂux values between pairs of reactions across
sampled metabolic states (Reed & Palsson, 2004; Becker
et al., 2007) and thereby determine metabolic dependencies
between reactions. From a more theoretical angle, sampling
was also used to evaluate the size of the set of possible ﬂux
distributions (Wiback et al., 2004; Braunstein et al., 2008).
When computed for distinct (genetic perturbation environ-
mental condition) pairs, the relative sizes of thecorresponding
ﬂux distribution sets were interpreted as indicators of the
respective diversity of metabolic states in the tested conditions
(Wiback et al., 2004).
The diversity of achievable metabolic ﬂuxes can also be
evaluated locally for each reaction. Flux variability analysis
was designed for this purpose: an optimization procedure
computes the minimal and maximal allowed ﬂux of each
reaction independently (Mahadevan & Schilling, 2003). This
procedure identiﬁes reactions that do not carry any ﬂux, or
conversely those that carry non-null ﬂux in all possible
metabolic states. Flux variability analysis has been broadly
used to predict the activity of reactions for speciﬁc sets of
metabolic constraints (Mahadevan & Schilling, 2003; Reed
& Palsson, 2004; Teusink et al., 2006; Feist et al., 2007; Henry
et al., 2007; Shlomi et al., 2007a).
Flux sampling or ﬂux variability approaches only provide
partial description of the set of possible ﬂux distributions.
To get a comprehensive picture of the possibilities, methods
which compute elementary modes (Schuster et al., 2000)
and extreme pathways (Schilling et al., 2000) have been
developed. These notions differ only slightly in their math-
ematical formulation (Klamt & Stelling, 2003; Papin et al.,
2004): the main idea is to determine the set of elementary
and independent metabolic routes that can occur in the
metabolic model. These elementary routes are ﬂux distribu-
tions that (1) respect all assumed constraints, including
steady state and irreversibility, and (2) are elementary in
the sense that they are composed of a minimal set of active
reactions. This second condition ensures that the ﬂux
FEMS Microbiol Rev 33 (2009) 164–190 c   2008 CEA–Genoscope
Journal compilation c   2008 Federation of European Microbiological Societies
Published by Blackwell Publishing Ltd.
174 M. Durot et al.distribution is not decomposable into a combination of
smaller elementary routes. It can be shown that any achiev-
able ﬂux distribution can be expressed as a combination of
such elementary routes. This property, together with the fact
that the set of elementary routes is unique, independently of
the method used to compute it (Klamt & Stelling, 2003), has
inspired numerous applications. This subﬁeld is also known
as metabolic pathway analysis. For instance, elementary
modes and extreme pathways have been used to exhaustively
describe the independent metabolic routes occurring in
newly reconstructed models, often sorted by metabolic
function (Schilling & Palsson, 2000; Van Dien & Lidstrom,
2002; Papin et al., 2002). The redundancy of routes can be
assessed and the respective yields of routes of conversion can
be compared (Papin et al., 2002). Conversely, the relative
importance of reactions in metabolism was scored using
elementary routes, reactions involved in many routes being
likely to be key players in metabolism (Stelling et al., 2002).
Finally, metabolicdependencies between reactions which are
stronger than those determined only by analyzing the correla-
tion of ﬂuxes in sampled distributions can be deduced from
knowing elementary routes. Reactions that always appear
jointly in elementary routes are bound to operate together
(Pfeiffer et al., 1999). The main obstacle in metabolic pathway
analysis is the size and complexity of the metabolic models, as
the number of elementary routes dramatically increases with
the size of the model (Yeung et al., 2007). The computation of
all routes is currently only tractable for medium-size models,
although signiﬁcant progresses have been made recently
(Terzer & Stelling, 2008).
Alternative approaches have been developed in order to
explore metabolic dependencies in models of larger size.
One of them, ﬂux coupling analysis, has become a popular
analytical tool (Burgard et al., 2004). Flux coupling analysis
identiﬁes all pairs of reactions whose ﬂuxes are always
coupled at steady state. It has been used in a wide range of
studies, and the resulting sets of coupled reactions were for
instance compared with correlations observed in the tran-
scriptional states of enzymes (Reed & Palsson, 2004;
Notebaart et al., 2008), interpreted with respect to the
structure of the metabolic regulation (Notebaart et al.,
2008), and used to study the horizontal transfer of genes
during bacterial evolution (P´ al et al., 2005a,b). Similar
methods were developed to study metabolic relationships
between metabolites, either by simply examining the
co-occurrence of metabolites in reactions (Becker et al.,
2006) or by determining conservation relations between
metabolites (Nikolaev et al., 2005; Imielinski et al., 2006).
This last type of method was applied to determine coupling
relationships between metabolite concentrations, identify
metabolite pools sharing conserved chemical moieties
(Nikolaev et al., 2005), and exhaustively predict distinct
minimal growth media for E. coli (Imielinski et al., 2006).
Prediction of growth phenotypes
One of the primary uses of genome-scale metabolic models
is the prediction of growth phenotypes (Price et al., 2004;
Palsson, 2006). Because these models aim at comprehen-
siveness, they are able to account for all main metabolic
processes contributing to growth, i.e. the production of
energy and biomass precursors from external metabolites.
Growth phenotypes cantherefore be predicted byexamining
towhich extent metabolic requirements for growth, in terms
of energy generation and biomass precursors synthesis, can
be fulﬁlled by ﬂux distributions from the model. Growth
phenotypes can be predicted either in a qualitative manner
(prediction of the mere ability to grow) by checking
piecemeal for the producibility of each biomass precursor
metabolite (Imielinski et al., 2005), or in a quantitative
manner (prediction of growth performance) by including a
biomass reaction consuming them in proportion to their
ratio in biomass composition and studying the ﬂux values it
can attain (Price et al., 2004). Determining biomass compo-
sition is therefore a necessary prerequisite to growth pheno-
type predictions. This is often achieved by examining the
relevant literature or adapting known biomass compositions
of related organisms. The Flux Balance Analysis (FBA)
method was speciﬁcally designed to predict quantitative
growth phenotypes (Varma & Palsson, 1994b; Price et al.,
2004). It computes the maximal growth yield achievable in
the metabolic model by maximizing the biomass reaction
ﬂux (representing the growth rate) given a set of bounded
intake rates for external substrates. FBA relies on the strong
assumption that bacteria have optimized their growth
performance in a subset of possible environments during
their evolution, thereby making the maximization of bio-
mass production a driving principle for metabolic operation
(Varma & Palsson, 1994b). This assumption has been
conﬁrmed by experiments in several cases (Edwards et al.,
2001). Using FBA, global quantitative relationships can be
predicted between the input rates of nutrients, the output
rates of byproducts, and the growth rate (Stephanopoulos
et al., 1998; Edwards et al., 2002; Price et al., 2004).
The global energy consumption of the cell can signiﬁ-
cantly inﬂuence the outcome of quantitative growth pheno-
type predictions. Two ATP hydrolysis ﬂuxes are added to the
models in order to properly account for it. One is constant
and models the non-growth-associated maintenance, which
represents the fraction of the energy demand necessary for
the cell survival that is independent from its growth rate, for
example to maintain the right ionic strength (Stouthamer &
Bettenhaussen, 1973). The second ﬂux is proportional to the
growth rate and corresponds to the energy demand asso-
ciated with growth beyond the mere requirements of meta-
bolic pathways – which are already directly accounted for in
the model – for example energy for cell division or assembly
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175 Genome-scale models of bacterial metabolismof higher order cell structures. These two parameters are
usually determined by ﬁtting growth yield predictions
derived using FBA to measured growth yields provided by
growth monitoring experiments (Reed et al., 2006a).
Measurements of growth yields for distinct growth rates are
sufﬁcient to ﬁt both growth-associated and non-growth-
associated maintenance parameters (Varma & Palsson,
1994a). The values of these parameters were determined
using experimental growth measurements for a signiﬁcant
proportion of reconstructed models (see Table 4).
Once ﬁtted, and assuming these parameters remain con-
stant across environments, the model can be used to predict
growth rates on different media (Edwards et al., 2001).
Predicted growth yields revealed to be consistent with
observed ones on a signiﬁcant number of media for E. coli
(Edwards et al., 2001). Inconsistencies between predicted
and observed growth yields can have multiple interpreta-
tions. First, the assumption of optimal substrate utilization
can be questionable for growth predictions on environments
that are not commonly encountered by the organism (Ibarra
et al., 2002; Schuster et al., 2008). Using an adaptive
evolution experiment on E. coli cells grown in glycerol
minimal medium, Ibarra and colleagues actually observed
that, while the initial growth yield was suboptimal, it
progressively evolved to reach the optimal value predicted
by the model. Other biological constraints, such as regula-
tion or capacity constraints, may also prevent the organism
from using optimal ﬂux distributions (Oliveira et al., 2005;
Feist et al., 2007). Comparing predictions of growth pheno-
types with experimental measures may also help in reﬁning
the model. A model component that is often reﬁned using
quantitative growth predictions is the stoichiometry of
proton translocation that occurs in reactions of electron
transport systems, such as the respiratory chain. These stoi-
chiometries are often hard to determine ap r i o r i , yet they
impact directly the P/O ratio and the efﬁciency of energy
generation (Reed et al., 2006a). With the help of a metabolic
model and growth yield measurements on several distinct
media, Feist et al. (2006) studied the unknown proton translo-
cation stoichiometry of such a reaction in Methano-
sarcina barkeri by determining for each media the model
maintenance parameters that provided the best growth yield
Table 4. Existing genome-scale metabolic models for bacterial organisms
Organism Reference Genes Reactions Metabolites
w
Experimental assessment
Wild-type
growth
phenotypes
Knockout mutant
growth phenotypes
Quantitative
growth
measures
Acinetobacter baylyi Durot et al. (2008) 774 875 701 173/190 (91%) 1138/1208 (94%) –
Bacillus subtilis Oh et al. (2007) 844 1020 988 200/271 (74%) 720/766 (94%) –
Clostridium acetobutylicum Lee et al. (2008a) 432 502 479 10/11 (91%) – X
Clostridium acetobutylicum Senger & Papoutsakis (2008) 474 552 422 – – –
Escherichia coli
z Feist et al. (2007) 1260 2077 1039 129/170 (74%) 1152/1260 (92%) X
Geobacter sulfurreducens Mahadevan et al. (2006) 588 523 541 – – X
Haemophilus inﬂuenza Schilling & Palsson (2000) 412 461 367 – – –
Helicobacter pylori
‰ Thiele et al. (2005) 341 476 485 – 54/72 (75%) –
Lactobacillus plantarum Teusink et al. (2006) 721 643 531 – – X
Lactococcus lactis Oliveira et al. (2005) 358 621 422 – – X
Mannheimia succiniciproducens Hong et al. (2004) 335 373 332 – – –
Mycobacterium tuberculosis Beste et al. (2007) 726 849 739 – 547/705 (78%) X
Mycobacterium tuberculosis Jamshidi & Palsson (2007) 661 939 828 – 132/237 (56%) X
Neisseria meningitidis Baart et al. (2007) 555 496 471 – – X
Pseudomonas aeruginosa Oberhardt et al. (2008) 1056 883 760 78/95 (82%) 893/1056 (85%) –
Pseudomonas putida Nogales et al. (2008) 746 950 710 84/90 (93%) 665/746 (89%)
z X
Rhizobium etli Resendis-Antonio et al. (2007) 363 387 371 – – –
Staphylococcus aureus Becker & Palsson (2005) 619 641 571 – – –
Staphylococcus aureus Heinemann et al. (2005) 551 774 712 – 8/14 (57%) –
Streptomyces coelicolor Borodina et al. (2005) 700 700 500 54/58 (93%) 11/12 (92%) X
First two columns of experimental assessment show the number of correct predictions among all experimentally determined qualitative growth
phenotypes. Last column speciﬁes whether the model has been assessed against quantitative growth rate measurements.
Number of distinct reactions including transport processes.
wNumber of biochemically distinct metabolites.
zThis model is an update of two earlier models for E. coli (Edwards & Palsson, 2000; Reed et al., 2003).
‰This model is an update of an earlier model for H. pylori (Schilling et al., 2002).
zUsing gene essentiality data for Pseudomonas aeruginosa.
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176 M. Durot et al.predictions for different hypothesized values of the stoichiome-
try. Assuming that maintenance should not signiﬁcantlychange
across media, they selected the stoichiometry that triggered the
smallest variation among the determined maintenance para-
meters across the environments. Other studies investigated the
stoichiometry of proton translocation in the respiratory chain
by directly exploiting measured ratios of electron acceptor (e.g.
oxygen, or Fe(III) in Geobacter sulfurreducens) consumption
rate vs. carbon source consumption rate and growth rate
(Heinemann et al., 2005; Mahadevan et al., 2006).
Models can readily predict the effect of gene deletion on
growth phenotypes. To that end, a layer of Gene Protein
Reaction associations – usually called GPR (Reed et al.,
2003) – is added to the model to predict the effect of gene
deletion on reaction activity. Each reaction is associated to
its enzyme-encoding genes by a Boolean rule: genes encod-
ing for subunits of an enzymatic complex are linked with an
AND rule, while genes encoding for alternative enzymes are
linked with an OR rule. Using GPR rules, gene deletions are
translated into ‘blocked’ reactions, which are then inacti-
vated in the model by constraining their ﬂuxes to zero. FBA
can be applied to predict growth phenotypes of gene knock-
out mutants. Nevertheless, the hypothesis of optimal growth
is largely debatable for such genetically engineered mutants,
as their metabolism was not exposed to evolutionary
pressure. Basing on the assumption that metabolism in a
knockout mutant operates as closely as possible to metabo-
lism in the wild-type strain, two speciﬁc methods were
introduced. They predict knockout mutant growth pheno-
types by minimizing either the overall ﬂux change [MoMA
(Segre ` et al., 2002)] or the number of regulatory changes
[ROOM (Shlomi et al., 2005)] between the wild-type strain
and the mutant strain (see Table 5). Both methods were
shown to provide slightly better predictions than FBA.
The throughput of experiments evaluating qualitative
growth phenotypes – i.e. described simply as viable or lethal
– has increased dramatically in the last few years. Phenotype
Microarrays from Biolog Inc. typically report growth phe-
notypes for several hundreds of media in a single experi-
ment (Bochner et al., 2001). In parallel to this, collections of
knockout mutants are being built for a growing number of
bacteria (Akerley et al., 2002; Jacobs et al., 2003; Kobayashi
et al., 2003; Baba et al., 2006; Liberati et al., 2006; Suzuki
et al., 2006; de Berardinis et al., 2008). The systematic
assessment of growth phenotypes of knockout mutants
provides a signiﬁcant resource for exploring the metabolic
capabilities of organisms and investigating their gene func-
tions (Carpenter & Sabatini, 2004), but their direct inter-
pretation is made difﬁcult by the complexity and size of
metabolic networks (Gerdes et al., 2006). These results can
be readily compared with model predictions, however,
providing a way to interpret them and assess the model
correctness. Given the qualitative nature of these growth
phenotypes, two types of inconsistencies may arise: false
viable predictions – growth was predicted yet not observed
experimentally – and false lethal predictions – growth was
not predicted yet observed experimentally. On the one hand,
these inconsistencies may be caused by limitations of the
model or cases where the modeling assumptions do not
hold. Regulation may for instance trigger a lethal phenotype
by blocking an alternate pathway, which would not be
predicted as blocked in the merely metabolic model. On
the other hand, examining the inconsistencies may identify
errors in the model and lead to its reﬁnement. All model
components may comprise errors, including the GPR asso-
ciations, the metabolic network itself, and the stated bio-
mass requirements. False lethal predictions are often clues
that some biomass component is actually not essential, or
that the model lacks an alternative gene or pathway that
would allow it to survive in the given experimental condi-
tions. Conversely, false viable predictions can help detect
missing essential biomass components, genes falsely anno-
tated as encoding isozymes or reactions that were wrongly
assigned or are inactive in the experimental conditions
(Duarte et al., 2004; Joyce et al., 2006). Growth phenotype
predictions have been evaluated for a signiﬁcant proportion
of reconstructed models, whenever experimental data were
available (see Table 4). Interpretation of inconsistent cases
by expert examination led to several annotation and model
reﬁnements, some of which were supported by the results of
targeted experiments (Covert et al., 2004; Duarte et al., 2004;
Joyce et al., 2006; Reed et al., 2006b). Automated methods
were recently introduced to systematically look for inter-
pretations of inconsistencies and possible modiﬁcations in
the model. Corrections of the GPR associations can be
systematically proposed that match the gene essentiality
observation with predicted reaction essentiality (M. Durot
et al., unpublished data). With regard to the metabolic
network itself, metabolic gap ﬁlling approaches have been
adapted to propose network corrections that resolve wrongly
predicted growth phenotypes (Reed et al., 2006b). Finally,
valuable insights into the determination of essential biomass
precursors can be provided by methods that analyze correla-
tions between lethality and metabolite production (Imielinski
et al., 2005; Kim et al., 2007). All these methods act indepen-
dently on distinct components of the model. A unifying
method integrating all types of corrections, which is yet to
come, could lead to an integrated platform for the systematic
interpretation of upcoming growth phenotyping results.
Models can actually predict growth phenotypes for any
environmental condition and any combination of gene dele-
tions, which is beyond reach of experiments. Given the
combinatorial complexity of mixing several gene deletions,
dedicated methods have been designed to analyze the effects of
multiple deletions and applied to identify epistatic interac-
tions between genes (Klamt & Gilles, 2004; Deutscher et al.,
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177 Genome-scale models of bacterial metabolism2006, 2008; Imielinski & Belta, 2008). Prediction of growth
phenotypes have also been used to automatically assign
condition-dependent roles to genes (Shlomi et al., 2007b),
investigate the causes of gene dispensability (Papp et al., 2004;
Kuepfer et al., 2005), or study bacterial evolution (P´ al et al.,
2005a, 2006). These two latter studies on bacterial evolution
used an E. coli model to analyze the effect of changing growth
environments on the acquisition of new metabolic capabilities
by horizontal gene transfer (P´ al et al., 2005a) and to simulate
the reductive evolution of metabolism in speciﬁc environ-
mental conditions (P´ al et al., 2006).
Model-based interpretation of experimental
data
The recent development of experimental techniques has
enabled measurements at genome-scale of several types of
quantities, generating so-called ‘omics’datasets. These data-
sets provide partial yet comprehensive snapshots of cellular
mechanisms (Ishii et al., 2007a), but their interpretation is
made difﬁcult by the volume of data. Computational
methods are thus needed if meaningful biological results
are to be extracted (Joyce & Palsson, 2006). A variety of
Table 5. Main analytical methods for genome-scale models sorted by type of application
Analysis of network properties
Flux sampling: random sampling of ﬂux distribution among the set of possible
metabolic states
Almaas et al. (2004), Reed & Palsson (2004), Wiback et al. (2004)
Flux variability analysis: examination of ﬂux variability for each reaction Mahadevan & Schilling (2003)
Metabolic pathway analysis, elementary modes/extreme pathways: comprehensive
description of all independent metabolic modes achievable in the metabolic network
Schilling et al. (2000), Schuster et al. (2000), Klamt & Stelling
(2003)
Flux coupling: identiﬁcation of reaction pairs whose ﬂuxes are coupled Burgard et al. (2004)
Metabolite coupling/evaluation of conserved metabolite pools Nikolaev et al. (2005), Becker et al. (2006), Imielinski et al. (2006)
Prediction and interpretation of bacterial growth phenotypes
Producibility analysis of biomass precursors Imielinski et al. (2005)
FBA: quantitative prediction of growth yield by maximization of growth rate given
bounded nutrient input rates
Varma & Palsson (1994a,b)
MOMA: prediction of gene deletion mutant ﬂux distribution by minimizing overall
ﬂux changes with wild type
Segre ` et al. (2002)
ROOM: prediction of gene deletion mutant growth by minimizing regulatory
changes with wild type
Shlomi et al. (2005)
Identiﬁcation of multiple gene deletion essentialities Klamt & Gilles (2004), Deutscher et al. (2006), Imielinski & Belta
(2008)
Model-based interpretation of experimental data
Metabolic ﬂux measurements
Metabolic Flux Analysis using labeled metabolites: prediction of attainable reaction
ﬂuxes given observed metabolite isotopic patterns
Wiechert (2001), Sauer (2006)
Global prediction of reaction activities using metabolic ﬂux measurements on
subsets of reactions
Herrg˚ ard et al. (2006a,b)
Identiﬁcation of metabolic objectives best describing observed ﬂuxes Burgard & Maranas (2003), Schuetz et al. (2007)
Metabolite concentrations
Comparison of model coverage with experimentally detected metabolites Oh et al. (2007)
NETanalysis and TMFA: application of thermodynamic constraints to reaction
directions using metabolite concentrations
K¨ ummel et al. (2006a,b), Henry et al. (2007)
Gene expression
Identiﬁcation of metabolic pathways correlated with gene expression levels Schwartz et al. (2007)
Reﬁnement of ﬂux distribution predictions by blocking reactions corresponding
to unexpressed genes
Akesson et al. (2004)
Evaluation of consistency of gene expression levels with metabolic objectives Becker & Palsson (2008)
rFBA and SR-FBA: prediction of gene expression states using Boolean regulatory
rules
Covert et al. (2001), Barrett et al. (2005), Barrett & Palsson
(2006), Shlomi et al. (2007a,b)
Metabolic engineering
Systematic identiﬁcation of gene deletions enhancing metabolite production yield Burgard et al. (2003), Patil et al. (2004), Alper et al. (2005a,b)
OptStrain: systematic identiﬁcation of reaction additions enabling the production
of novel metabolites
Pharkya et al. (2004)
Prediction of adjustments of enzyme expression levels enhancing metabolite
production yield
Pharkya & Maranas (2006), Lee et al. (2007)
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178 M. Durot et al.methods have been developed to exploit experimental data
related to metabolic states, for example measurements of
metabolic ﬂuxes, metabolite concentrations, enzyme levels,
or gene expression,in the light of genome-scale models. Two
cases generally arise: either experimental observations are
directly comparable to model predictions, or these observa-
tions lead to the imposition of additional constraints that
reﬁne the set of predicted metabolic states. Observations
falling in the second category allow for instance the selection
of those metabolic routes that are compatible with the
experimental observations, or help predict quantitative values
for the ﬂuxes. When directly comparable to model predic-
tions, experimental data may be used to assess model correct-
ness and assumptions, identify inconsistencies, and target
improvements, as illustrated above with growth phenotypes
(Reed et al., 2006b). We will review such integration methods
in the following sections for three types of experimental data:
measurement of (1) reaction ﬂuxes, (2) metabolite concentra-
tions, and (3) gene expression levels.
Reﬁning the model with experimental data increases its
correctness with respect to the observations but may
decrease its predictive power. Predictions performed with a
reﬁned model should actually be interpreted with care to
avoid circular reasoning: data that have been directly used to
improve the model can no more be considered as predic-
tions, they are part of the evidences on which the model is
based to perform predictions. For instance, a model whose
maintenance parameters have been determined using
growth rate measurement can no more predict the growth
rate for the environmental condition. This problem can
become serious when models are extensively ﬁtted with
experimental data, as they then become more descriptive
than predictive. Nevertheless, some reﬁnement processes
applied to genome-scale models involve ﬁnding additional
biological evidence that supports the reﬁnement, thereby
breaking the circular reasoning. For instance, corrections of
inconsistent growth phenotype predictions by additions of
alternate enzymes often involve ﬁnding additional proofs
that the introduced enzymes possess the right activity.
Metabolic ﬂux measurements
One of the most direct experimental accesses to metabolic
ﬂuxes is provided by atom-labeling experiments (Wiechert,
2001; Sauer, 2006). By analyzing the fate of labeled metabo-
lites, valuable information can be deduced about the reactions
that are actually taking place. The most common technique
for this consists in analyzing the stable isotope patterns
(mostly using
13C) found in products of metabolism given
known isotope patterns in nutrient metabolites (Wiechert,
2001; Sauer, 2006). These data can be properly interpreted
only using a metabolic model that includes information about
atom mappings for each reaction (Zupke & Stephanopoulos,
1994; Wiechert et al., 1999; Antoniewicz et al., 2007a). Such
models have been built for a few organisms, often using
existing constraint-based models as a basis (Antoniewicz
et al., 2007b; Suthers et al., 2007). While atom mappings for
reactions are currently mostly inferred using chemoinfor-
matics methods (Raymond et al., 2002; Arita, 2003; Hattori
et al., 2003), this information will likely be made accessible in
dedicated databases in the coming years.
By qualitatively examining isotope patterns in nutrients
and products, information can already be extracted about
the possible routes of conversion (van Winden et al., 2001;
Sauer, 2006; Kuchel & Philp, 2008). Patterns in products
actually depend on their biosynthetic pathways. Observed
patterns that are inconsistent with the predicted possible
patterns are clues that other pathways may occur in vivo.
This approach was for instance recently used to evaluate the
model of G. sulfurreducens: an inconsistent isotope pattern
for isoleucine led to the discovery of an isoleucine biosynth-
esis pathway previously uncharacterized in this bacteria
(Risso et al., 2008).
Quantitative interpretation of isotope patterns together
with measurement of extracellular metabolite ﬂuxes can help
determine the value of intracellular reaction ﬂuxes using
Metabolic Flux Analysis (Zupke & Stephanopoulos, 1994;
Stephanopoulos et al., 1998; Wiechert et al., 1999; Sauer,
2006; Antoniewicz et al., 2007a). Known ﬂux values can then
be directly exploited in models to characterize which meta-
bolic pathways are operating and quantify their ﬂuxes. As an
application, Herrg˚ ard et al. (2006a) introduced the optimal
metabolic network identiﬁcation method, which combines
ﬂux measurements for a fraction of the reactions with the
assumption of optimal growth from FBA to globally infer
which reactions are active. This method has been for instance
used to identify bottleneck reactions that limit the growth in
engineered strains, and discard putative reactions from newly
reconstructed models (Herrg˚ ard et al., 2006a).
Observed ﬂuxes were also used to determine relevant
objective functions to choose when predicting metabolic
states with FBA (Burgard & Maranas, 2003). By evaluating
the match of predicted ﬂuxes with observed ones, these
studies could identify those metabolic objectives that pro-
vided the best ﬁt. Distinct objectives, including maximiza-
tion of ATPor biomass yields, were identiﬁed for instance in
E. coli depending on the environmental conditions (Schuetz
et al., 2007). Observed metabolic ﬂuxes, however, often
show that metabolism does not necessarily operate accord-
ing to optimality principles (Fischer et al., 2004), especially
when regulatory constraints are overlooked.
Metabolite concentrations
High-throughput measurement of intracellular metabolite
concentrations is becoming common practice thanks to
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179 Genome-scale models of bacterial metabolismrecent developments in MS and NMR technologies (Dunn
et al., 2005; Dettmer et al., 2007). Metabolite proﬁling experi-
ments commonly detect thousands of peaks, among which
hundreds can usually be exploited to identify metabolites and
determine their concentrations, using for instance known
spectra of reference metabolites (Dunn et al., 2005). These
datasets, while not fully comprehensive, provide signiﬁcant
information on metabolites present in the cell.
Merely comparing the set of detected metabolites to the
set of metabolites present in the model already help in
assessing the comprehensiveness of the model. For example,
in the reconstruction process of Bacillus subtilis metabolic
model, Oh et al. (2007) evaluated the overlap between
model metabolites and intracellular metabolites identiﬁed
in a metabolomics dataset; among 350 intracellular metabo-
lites identiﬁed, only 160 were present in the model. No
previously known biochemical activities could be associated
with the remaining metabolites, illustrating the fact that a
large part of B. subtilis metabolism remains unknown. These
unaccounted metabolites can guide further investigations
on missing activities, leading to expansion of the model’s
metabolite scope consequently.
By extending the constraint-based modeling framework to
encompass thermodynamic constraints on Gibbs energies of
reactions, knowledge of absolute metabolite concentrations
can be translated into constraints on ﬂux directions (K¨ ummel
et al., 2006b; Henry et al., 2007). A ﬁrst application is
to check the consistency of metabolomic datasets with respect
to metabolic ﬂuxes predicted by the model. Methods
and software have been developed to pinpoint inconsistent
concentration measures (Zamboni et al., 2008). Conversely,
metabolomic-derived constraints reﬁne the characterization
of metabolic ﬂuxes within the model; their integration has
allowed the prediction of ranges of concentrations for un-
measured metabolites, reaction directions, and ranges of
Gibbs energies of reactions, identifying thereby potentially
regulated reactions (K¨ ummel et al., 2006b).
Thermodynamic constraints merely enforce link between
the concentrations of metabolites and the directions of
reactions. Taking reaction kinetics into consideration could
reinforce that link and make it more quantitative. Extending
models to handle kinetics is still an open issue (Famili et al.,
2005; Yugi et al., 2005; Ishii et al., 2007b; Smallbone et al.,
2007; Covert et al., 2008; Jamshidi & Palsson, 2008), all the
more challenging because of the potential inﬂuence of
regulation, the scarcity of kinetic parameter values and the
lack of scalable analytical methods.
Gene expression data
Thanks to technological advances, gene expression levels are
among the most widely accessible type of ‘large-scale’ experi-
mental data. While such datasets provide a global overview of
the level of expression of enzymes, deriving information on
reaction ﬂuxes from gene expression levels is hindered by the
numerous biological processes intervening between them.
Changes in rates of translation or mRNA and enzyme
degradation may signiﬁcantly modify the quantity of enzymes
available from a given amount of transcript. In addition,
changes in substrate/product concentrations or metabolic
regulations can inﬂuence the reaction ﬂuxes irrespective to
the enzyme quantities. As a consequence, no simple correla-
tions are necessarily observed between gene expression levels
and reaction ﬂuxes (Gygi et al., 1999; ter Kuile & Westerhoff,
2001; Yang et al., 2002; Akesson et al., 2004).
Some approaches have nonetheless been developed to
exploit information from gene expression data using models.
In the vein of pathway- or module-based methods interpret-
ing changes of gene expressions at the level of pathways or
biological processes (Hanisch et al., 2002; Draghici et al.,
2003; Yang et al., 2004), methods relying on a graph repre-
sentation of metabolism (Patil & Nielsen, 2005) or on a
decomposition of metabolic models into elementary modes
(Schwartz et al., 2007) were introduced to correlate expres-
sion levels with possible metabolic states. These approaches
are merely descriptive: the model provides a suitable meta-
bolic context to interpret the experimental data. Gene expres-
sion data have also been used to reﬁne the characterization of
metabolic ﬂuxes in models. For instance, by blocking reac-
tions corresponding to unexpressed genes, metabolic ﬂuxes
could be characterized more precisely in a yeast model
(Akesson et al., 2004). In the same spirit, a method was
recently introduced to evaluate the consistency of gene
expression datasets with metabolic objectives, and identify
subsets of active reactions that best correlate with expressed
genes and metabolic objectives (Becker & Palsson, 2008).
Even though these methods only rely on a limited depen-
dency between gene expression level and reaction ﬂux –
reactions catalyzed by unexpressed genes should have low
ﬂuxes – they succeed in somewhat improving the character-
ization of metabolic states, or in assessing the consistency of
the model with the experimental data.
As an attempt to account for transcriptional regulation,
regulatory interactions were introduced in models by trans-
lating them into Boolean rules (Covert et al., 2001). In such
joint regulatory-metabolic model, Boolean variables quali-
tatively describe the transcription state of genes, including
genes coding for enzymes and transcription factors, while
Boolean rules determine their regulatory dependencies.
Metabolic reactions are then allowed to have a nonzero ﬂux
only if the transcriptional state of their enzymes is true.
Several methods have been developed to study these joint
models. Regulatory FBA (rFBA) simulates time courses of
gene expression states: at each time step, the new transcrip-
tional state is computed from the metabolic state predicted
at the previous time step, and is used to constrain FBA
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180 M. Durot et al.prediction of the current metabolic state (Covert et al.,
2001). A speciﬁc representation scheme was later developed
to encode the sequence of expression states predicted by
rFBA in a uniﬁed manner, in order to compare regulatory
responses across various environments (Barrett et al., 2005).
Another type of method has been recently developed to
determine joint steady states of gene expression and meta-
bolic ﬂuxes. Examining these steady states contributed to
the identiﬁcation of redundantly expressed enzymes and the
quantiﬁcation of the effect of transcriptional regulation in
determining ﬂux activity in E. coli (Shlomi et al., 2007a).
Finally, two studies compared experimental expression
levels with predicted expression states to assess the correct-
ness of joint regulatory-metabolic models of E. coli and yeast
(Covert et al., 2004; Herrg˚ ard et al., 2006b). A signiﬁcant
proportion of inconsistent expression states could be cor-
rected in these models by searching for missing interactions
(Covert et al., 2004; Herrg˚ ard et al., 2006b). In the same
vein, a method was recently designed to automate the
identiﬁcation of experiments that are likely to bring most
information on potentially missing regulatory interactions
(Barrett & Palsson, 2006).
Using genome-scale models for metabolic
engineering
The use of microbial organisms for industrial purposes has
grown considerably in the past few years, with potential
applications ranging from the production of valuable meta-
bolites to the degradation of pollutants and the generation
of renewable energy (Janssen et al., 2005; Ro et al., 2006;
Peng et al., 2008; Rittmann, 2008). The ﬁeld of metabolic
engineering aims at designing and improving industrial
microorganisms through the rational design of genetic
manipulations leading to enhanced performance (Bailey,
1991; Stephanopoulos et al., 1998). With the advent of
genome-scale experimental technologies, the set of meta-
bolic engineering methods is progressively expanding to
include systems-wide analyses, enabling for instance to
study the operation of regulatory and metabolic networks
at large scale (Park et al., 2008). In this respect,genome-scale
metabolic models provide to engineers an effective toolbox
to investigate the metabolic behavior of their strain of
interest and target improvements (Kim et al., 2008).
As a ﬁrst class of applications, all analytical methods
presented in the previous sections can be directly applied to
engineering purposes. Such methods may help for instance
to evaluate the maximum theoretical efﬁciencies of path-
ways or determine appropriate host strains by predicting
their metabolic capabilities from their reconstructed
models. More importantly, metabolic models can help in
characterizing the actual metabolism operation of engi-
neered strains, especially when experimental data have been
acquired on them. Metabolic Flux Analysis provides for
instance quantitative values for intracellular ﬂuxes, which
may be used to determine the actual pathway utilization and
pinpoint bottleneck reactions (Stephanopoulos et al., 1998).
Such information is of high signiﬁcance for the metabolic
engineers, as it may help them in designing further meta-
bolic modiﬁcations.
Metabolic models also provide the ability to formulate
hypotheses and evaluate in silico the potential of genetic
modiﬁcations. A common cause of low production yields
lies in the presence of pathways that divert ﬂuxes to the
production of undesirable byproducts or compete for the
utilization of precursors and cofactors. While such pathways
may be identiﬁed manually, their direct removal through
gene deletion may cause side effects, for example alter the
regeneration of cofactors, the redox balance, or the energy
balance (Kim et al., 2008). Genome-scale models can predict
the effect of gene deletions on metabolic phenotypes. Several
methods were designed with the aim of selecting those gene
deletions that would provide the greatest beneﬁt for a given
metabolite production goal. Alper et al. (2005a) developed a
procedure that sequentially screen the effect of single and
multiple gene deletions in order to select those enabling the
best product yields while maintaining sufﬁcient growth
rates. They successfully applied their method to enhance
the yield of a lycopene producing E. coli strain (Alper et al.,
2005b). Screening in silico the high number of combinations
of multiple gene deletions may turn out to be costly and
practically impossible. Optimization methods based on
genetic (Patil et al., 2005) or linear programming (Burgard
et al., 2003) algorithms were introduced to circumvent this
issue. The second optimization method, called OptKnock,
speciﬁcally searches gene deletions coupling the production
of atargeted metabolite withgrowthrate; the rationale being
that improving the growth rate by adaptive evolution would
jointly improve the metabolite production rate and that this
coupling would make the engineered strain more evolu-
tionary stable (Burgard et al., 2003). Gene deletions pro-
posed by this method were tested experimentally to enhance
lactic acid production in an E. coli strain (Fong et al., 2005).
Adaptive evolution experiments performed on the engi-
neered strains actually showed that lactic acid production
was coupled to growth and achieved increased secretion
rates of the product.In addition to gene deletions, metabolic
models can explore the effect of adding new pathways,
and help select the most appropriate ones. In this aim,
the OptStrain method was designed to systematically sug-
gest additions of reactions to produce novel metabolites
(Pharkya et al., 2004). OptStrain relies on a comprehensive
database of biochemical reactions and may propose alter-
native solutions. A last set of methods consists in designing
suitable up- or downregulations of metabolic enzymes.
Intervening on gene expression levels is indeed a powerful
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181 Genome-scale models of bacterial metabolismtool to tune metabolism operation, but the speciﬁc effects of
such interventions are often hardly predictable (Kim et al.,
2008). In a study involving a L-threonine producing strain of
E. coli, Lee et al. (2007) made use of its metabolic model to
predict gene expression changes enhancing the strain yield.
Speciﬁcally, they predicted ﬂux values of key reactions
leading to optimal L-threonine production and compared
them with measured ﬂuxes. They then used the relative
difference between them to guide the tuning of the expres-
sion of the corresponding genes. A more systematic
approach was introduced with the OptReg method, which
identiﬁes at genome-scale the relative changes of ﬂux values
with respect to the wild-type ﬂux distribution that provide
the best production yield (Pharkya & Maranas, 2006).
Results of OptReg can be used to identify candidate enzymes
for up- or downregulation.
Yet, two main issues limit the predictive capabilities of
metabolic models. First, while regulation may play a central
role in controlling the efﬁciency of product synthesis, it is
completely overlooked in metabolic models. Studying regu-
latory interactions – using for instance models of regulatory
networks – may actually provide useful insights, for example
to remove feedback inhibitions or ﬁne-tune transcriptional
regulatory circuits commanding the product biosynthesis
(Kim et al., 2008). Not accounting for enzyme quantities but
only reaction ﬂuxes imposes a second limitation to genome-
scale models. Implementing changes in ﬂux values – sug-
gestedforinstancebymetabolicmodeloptimizationmethods
– by altering the quantity of enzymes is a difﬁcult task, as
enzyme kinetics and metabolite concentrations may signiﬁ-
cantly inﬂuence the ﬂux change. In order to determine the
effect of enzyme quantity changes on metabolic ﬂuxes, more
detailed approaches are required, for example metabolic
control analysis (Fell, 1992).
Resources, databases, and tools
At the time of this review, genome-scale models have been
reconstructed for at least 17 bacteria (see Table 4). For all of
them, extensive manual curation was required in order to
integrate information from the literature on their biochem-
istry and physiology with functional information from
genome annotation. These models are therefore of high
quality on average, and mostly complete with respect to the
current knowledge of their metabolism. An increasing sub-
set is being assessed and corrected against large-scale experi-
mental data (see Table 4), and an impressive array of
analytical studies has been applied to the most popularones,
for example E. coli (Feist & Palsson, 2008).
Models used to be made available independently by their
authors, under a variety of naming conventions and for-
mats. This is a signiﬁcant obstacle to their reusability, as
signiﬁcant effort is required to adapt them to modeling
software other than the ones they were constructed with.
Differences in reaction and metabolite names also hamper
direct comparisons between different models. Fortunately,
some attempts to address these issues are under way. The
general-purpose SBML format (Systems Biology Markup
Language) (Hucka et al., 2003) is often used to exchange
constraint-based models, thus playing the role of a ‘default’
standard for models. While SBML can be imported by many
modeling tools, it is not fully adapted to the speciﬁcs of
models; this may result in information or functionality loss
during exchange. In addition to providing a standard format,
SBML supports the association of model components with
externalreferences,suchasreactionandmetaboliteidentiﬁers
in universal metabolic databases, using MIRIAM annotations
(Le Nove `re et al., 2005). If widely used, this feature should
facilitate model reuse and comparison.
In order to facilitate model reuse and comparison,
dedicated model repositories have been developed. Perhaps
the most widely adopted initiative of this type is the
Biomodels.net repository (Le Nove `re et al., 2006) which
stores biochemical models of any type in SBML format.
Because of its focus on more detailed dynamic models and
the related generic format choice, the repository is not fully
compatible with constraint-based models and qualitative
predictions, as illustrated by the current low number of such
models included. Agreements with several journals make it
mandatory for authors to deposit models mentioned in
their manuscripts in Biomodels.net, where they are checked
for syntactic correctness. On some models, a more elaborate
test on the compatibility between model predictions and
results presented in the associated paper is also performed.
Currently, the only freely accessible (to academic users)
repository dedicated to constraint-based models is the BiGG
database (http://bigg.ucsd.edu). Its uniﬁed dictionary of me-
tabolite and reaction names enables direct comparisons
between its metabolic models.
Relatively few software tools have been speciﬁcally devel-
oped to handle genome-scale constraint-based models,
compared with the number of tools developed for kinetic
modeling. As the modeling framework relies primarily on
linear algebra and linear programming, general purpose
mathematical software platforms, for example MATLAB
(http://www.mathworks.com/) and MATHEMATICA (http://
www.wolfram.com/), or optimization modeling packages,
for example GAMS (http://www.gams.com/), are well suited.
Specialized optimization packages can be added for greater
efﬁciency. In addition, modules dedicated to constraint-based
modeling have been developed for MATLAB: FLUXANALYZER
(Klamt et al., 2007), the COBRA TOOLBOX (Becker et al.,
2007), or METATOOL (von Kamp & Schuster, 2006) for
elementary mode analysis aregood representatives. Libraries
for importing SBML models within these programs are also
provided by the SBML developer community (Bornstein
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one should mention the SYSTEMS BIOLOGY RESEARCH TOOLBOX
(Wright & Wagner, 2008), SCRUMPY (Poolman, 2006), META-
FLUXNET (Lee et al., 2003), or FLUXEXPLORER (Luo et al., 2006),
eachwith their own speciﬁc strengths. Interestingly, very few
programs focus or even support the model reconstruction
process by providing the analytical capabilities for consis-
tency checks: the commercial SYMPHENY platform (http://
www.genomatica.com/) associates a metabolic database
with several analytical methods, while YANASQUARE (Schwarz
et al., 2007) facilitates the reconstruction of models from
KEGG and performs selected structural analyses (e.g. ele-
mentary modes). Very recently, web-based tools have been
released to enable on-line analyses on speciﬁc metabolic
models (Beste et al., 2007; Durot et al., 2008). Given the
need for faster and better reconstruction, we expect more
progress in that direction.
Concluding remarks and future directions
Constraint-based genome-scale metabolic models can be
viewed as ‘systems-level’ analytical layers which enable com-
putation and reasoning on the consequences of the accumu-
lated knowledge on the biochemistry encoded in a given
genome,andconfrontationofthatknowledgewiththeknown
physiology of the corresponding species or with additional
experimental evidence. These models thus bridge the gap
betweengenotype andphenotype and enableawidespectrum
of analyses and in silico experiments, providing a solid
foundation for systems analyses and metabolic engineering.
The systematic and automated reconstruction of genome-
scale models from genomes and additional high-throughput
data may seem like a natural extension of genome annotation
(Reed et al., 2006a), but remains beyond the reach of current
methods. While genome-scale models can be reconstructed
using only sequence and qualitative functional information,
gaining the additional predictive and analytical power of
models still requires signiﬁcant effort and expertise. Genome
annotations must ﬁrst be translated into a network, which
must then be turned into a model with the help
of additional information, and systematically checked with
respect to biochemical consistency rules and experimental
observations. Only after a model is complete enough to
enable meaningful predictions at the phenotypic level can it
be used to predict phenotypes or other properties beyond
those that can be immediately veriﬁed.
Obstacles to automating this process include technical
difﬁculties in translating annotations into proper biochem-
ical activities, and also the fact that methods for model
reﬁnement have been designed and applied separately for
each type of experimental data. There is increasing pressure
for this situation to evolve, however, as the boost in the
throughput of experimental techniques and the advent of
‘multi-omics’ datasets (Ishii et al., 2007a) promises a wealth
of information that will be exploitable only by computer-
assisted interpretation, with the help of models. At the same
time, the ﬁeld of metabolic modeling is now approaching
the level of maturity necessary for several data integration
methods to be used together as components in integrated
model reconstruction and reﬁnement strategies.
Signiﬁcant beneﬁts could result from the availability of a
wider spectrum of bacterial metabolic models. They would
provide an integrated view of metabolic pathways across the
tree of life, thereby enabling so-called transverse approaches
to annotation, and a variety of comparative metabolic
analysis. To that end, the notion of pathway – deﬁned
unambiguously as the conversion between speciﬁed sets of
input compounds (reactants) and output compounds (pro-
ducts) – can bring a useful decomposition of metabolism
into basic biochemical functional units, in the spirit pio-
neered by SEED (Overbeek et al., 2005), KEGG Modules
(Kanehisa et al., 2007), or MetaCyc (Caspi et al., 2006). The
ﬁeld of bacterial evolution is poised to beneﬁt as well: for
instance, the availability of models for several bacteria along
the phylogenetic tree would allow more comprehensive
studies on the constraints implied by bacteria’s metabolic
capabilities and their evolution. While this type of study has
been pioneered with a few selected models (P´ al et al., 2005a,
2006), working with a larger set of models will undoubtedly
bring different insights (see (Kreimer et al., 2008) for an
example with networks). Modeling can also help in studying
bacterial communities, as chemical interactions occurring
between bacteria often need to be understood within the
context of their metabolisms. Indeed, models have already
been reconstructed and analyzed for small communities
(Stolyar et al., 2007); progress on that front may prove very
useful in studying metabolic interactions in more complex
communities, assisting in the functional interpretation of
metagenome sequences. Last but not least, metabolic en-
gineering applications would clearly beneﬁt from the avail-
ability of a large set of bacterial models, as these would
constitute a repository of characterized metabolic pathways,
facilitating the combinatorial design of new catalytic sys-
tems, providing solid bases to test hypothetical genetic
constructions, and helping with the selection of relevant
strains for speciﬁc engineering objectives.
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